Charles M. Rudin, M.D., PH.D.
NPI 1467483404ActiveIndividual· Internal Medicine, Hematology & Oncology· New York, NY
Internal Medicine, Hematology & Oncology (M.D., PH.D.) in New York, New York, trained at University of Chicago, Pritzker School of Medicine (class of 1993). Their prescriptions cost Medicare Part D more than their services did: $1,052,950 for 362 claims, against $34,129 paid for services in 2024. Daiichi Sankyo Inc. was the largest of 9 companies reporting payments in 2025, $40,408 in all, mostly consulting fees.
Overview
| NPI | 1467483404 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D., PH.D. |
| Sole proprietor | No |
| NPI issued | Jul 6, 2006 |
| Last updated in NPPES | Apr 7, 2015 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Hematology & Oncology Primary | 207RH0003X | D61040 | MD |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Medical Oncology (NY) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 83 |
|---|---|
| Services billed | 280 across 8 procedure codes |
| Paid by Medicare | $34,129 |
Part D prescriptions in 2024
| Prescriptions (claims) | 362 · 392 30-day fills |
|---|---|
| Patients | 51 |
| Total drug cost | $1,052,950 |
| Generic share | 67% of claims |
Education and affiliations
| Medical school | University of Chicago, Pritzker School of Medicine |
|---|---|
| Graduation year | 1993 |
| Medicare specialty | Medical Oncology |
| Telehealth | Offers telehealth |
Medical group
- Memorial Solid Tumor GroupNew York, NY · 234 clinicians
Industry payments (Open Payments)
- 2025$40,408 · 30 payments from 9 companies
- 2024$14,664 · 15 payments from 7 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Daiichi Sankyo Inc. | $14,135 | 7 |
| Merck Sharp & Dohme LLC | $13,051 | 10 |
| Amgen Inc. | $3,528 | 3 |
| Abbvie Inc. | $3,527 | 3 |
| Beone Medicines USA, Inc. | $3,000 | 1 |
What the 2025 payments were for
- Consulting Fee$23,093 · 10 payments
- Travel and Lodging$12,227 · 10 payments
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$4,480 · 1 payment
- Food and Beverage$608.45 · 9 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other hematologist-oncologists in New York
- 1003115700
- 1003307513
- 1023336518
- 1033568324
- 1053586263
- 1063537041
- 1073907630
- 1083389290
- 1083980189
- 1093785396
- 1104847508
- 1114192242
All 399 hematologist-oncologists in New York · All hematologist-oncologists in New York